We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
Price data last checked 152 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 16 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 318 days • 318 data points (No recent data available)
Price Distribution
Price distribution over 318 days • 1 price levels
Price Analysis
Most common price: £520 (318 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 318 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLQF7XM2
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City
The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
Multiple Sclerosis in Children and Adolescents - Medical Book
The 2023-2028 Outlook for Medical Foods in the United States
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
The 2023-2028 Outlook for Digital Therapeutics Sales in India
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
IntechOpen
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
The 2023-2028 Outlook for Anti-Malarial Drugs in India
The 2023-2028 Outlook for Bio-Based Food Ingredients in India
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
The 2023-2028 Outlook for Medical Imaging Analysis Software in India
The 2023-2028 Outlook for Mobile Medical Apps in India
